New Technology Challenges the Inevitability of Osteoporosis: Introduction (04:13)

FREE PREVIEW

Exercise prevents, controls, or reverses most items in the healthcare continuum. Dr. Jason Conviser outlines the presentation's agenda and discloses his potential conflicts.

Physiology and Osteoporosis (04:21)

Bones are living tissue and are either cortical or trabecular. Osteoporosis is characterized by low bone mass and bone tissue deterioration; see images of osteoporotic bones. Osteoporosis is one of the fastest growing disease states.

Risk Factors and Bone Density (02:29)

Conviser lists 12 risk factors of osteoporosis. Exercise and activity is declining in our culture. See the total body bone mineral content adjusted by age and the stages of bone growth and loss.

So What? (03:04)

See statistics on the effects of hip fractures for individuals over the age of 50. Bone densitometry (DXA) measures bone density; the greater the T-score, the greater the risk of bone fracture.

Preventing/Changing Bone Disease (03:04)

Conviser explains what the medical, pharmacological and fitness industries are doing to prevent and delay the onset of osteoporosis; ACSM exercise recommendations are not effective. Wolff's Law summarizes over 100 years of science regarding the deformation of bone. Maximum loading increases bone mineral density.

Osteogenic Loading (05:40)

Dr. John Jaquish explains how the bioDensity device works; it has four maximum load exposures. Forces that compress the bone are typically multiples of body weight; nerves react to the deformation and pull minerals into the bone once the compression releases.

bioDensity Device (03:33)

Dr. Jaquish explains the development of the device. Users increase force production by an average of 90% over nine weeks. Out of 500,000 users, no injuries were reported. Review a DXA scan pre-bioDensity use and post-bioDensity use after one year.

Entrepreneurship (05:27)

Faris Al Turki discusses establishing his restaurant; youth development is the point of focus for the Islamic Development Bank meeting. Mr. Usta links UAE residents with tradespeople. Dubai SME supports small and medium sized enterprises.

Opportunity (04:06)

Medical wellness centers have the opportunity to measure and reveal outcomes that excite people. Conviser discusses implementing three month bioDensity programs for clients and program benefits.

Arabian Travel Market (02:32)

The tourism trade show is the largest meeting place for industry participants. Signs indicate a positive recovery for some tourism sectors; India and China are major markets. Tourism accounts for over 12% of the UAE's GDP.

Financial Services Market (06:18)

Dubai's economic diversification includes Islamic finance, startups, retail, and entertainment; the DIFC is the leading financial hub of the MEASA region. Fintech Hive connects tech entrepreneurs with banks. Arif Amiri discusses combining products with development strategy, anticipated growth, and asset management.

Q/A: Is a Fracture a Contraindication? (01:13)

The two contraindications for using the bioDensity device are muscular dystrophy and un-medicated hypertensive.

Q/A: Decrease in Hip Fracture Incidents? (00:45)

Jaquish does not currently have data supporting a decrease; it is a long-term study. The bioDensity device compresses the entire bone so the entire bone receives stimulus.

Q/A: FDA Approval (00:51)

The bioDensity device is FDA registered and can be marketed as an osteoporotic treatment device.

Q/A: What about Knee and Hip Replacement? (00:41)

Many individuals with joint replacements have used bioDensity with success. All joint replacements are designed for high impact activity.

Q/A: National Registry (02:16)

The bioDensity website contains a location finder. Conviser reflects on the current and future success of the device; T-scores are changing. The bioDensity device is additive.

Q/A: Age Recommendations and Session Time (02:53)

Individuals over the age of 100 have used the bioDensity device. Current studies are identifying specific age populations and group studies. A single session can take up to 15 minutes, depending on the facility and patient.

Q/A: Subset with Increase (01:33)

Conviser and Jaquish did not perform pre and post DXA scans on every individual. The subset was selected independently.

Q/A: One Rep Maximum vs. bioDensity (02:09)

Jaquish uses a bench press to compare the load capacity and range an individual can reach on his or her own versus the bioDensity device. The load is on the bone, rather than the muscle.

Q/A: Time Frame and Money (03:30)

Individuals will see results from the bioDensity device in approximately 12 weeks. Charge a specific amount for the 12 weeks and then charge a maintenance fee per year; guarantee results.

Credits: New Technology Challenges The Inevitability of Osteoporosis (00:25)

Credits: New Technology Challenges The Inevitability of Osteoporosis